Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities

ABSTRACT Background: Non-metastatic castration resistant prostate cancer (M0 CRPC) has seen important developments in drugs and diagnostic tools in the last two years. New hormonal agents have demonstrated improvement in metastasis free survival in M0 CRPC patients and have been approved by regulat...

Full description

Bibliographic Details
Main Authors: Fernando Maluf, Andrey Soares, Guilherme Avanço, Aline Lury Hada, Ana Paula Garcia Cardoso, Arie Carneiro, Daniel Herchenhorn, Denis Leonardo Fontes Jardim, Fabio Augusto Schutz, Fabio Roberto Kater, Felipe Moraes Toledo Pereira, Fernando Sabino Marques Monteiro, Igor Alexandre Protzner Morbeck, João Francisco Navarro Reolon, Karine Martins da Trindade, Livia Maria Querino da Silvo Andrade, Lucas Mendes Nogueira, Renato Furoni, Ricardo Azze Natel, Rodolfo Borges dos Reis, Rodrigo Nogueira Fogace, Vinicius Carrera Souza
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2021-02-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382021000200359&tlng=en